Moore Michael 4

What Happened
Michael Moore, President of Viemed Healthcare (VMD), sold a total of 136,802 shares in three open‑market transactions between 2026-03-18 and 2026-03-20. Breakdown by date:

• 2026-03-18: 31,570 shares at a weighted average $9.42 — $297,389
• 2026-03-19: 40,232 shares at a weighted average $9.21 — $370,537
• 2026-03-20: 65,000 shares at a weighted average $8.77 — $570,050
  Total proceeds across the three disposals: approximately $1,237,976. These were sales (dispositions), not purchases.

Key Details

• Transaction dates: 2026-03-18, 2026-03-19, 2026-03-20. All reported on Form 4 filed 2026-03-20. Form 4s are generally due within 2 business days, so this filing appears timely.
• Prices: reported as weighted averages. Footnotes state the underlying trade price ranges:
  • F1 (3/18): trades ranged $9.26–$9.61
  • F2 (3/19): trades ranged $9.04–$9.38
  • F3 (3/20): trades ranged $8.63–$9.18
    The filer offers to provide the per‑trade breakdown on request.
• Shares owned after the transactions: not specified in the excerpt provided (check the full Form 4 for post‑transaction holdings).
• No footnote indicates a 10b5‑1 plan, option exercise, gift, or tax withholding tied to these sales in the provided data.

Context
These were outright sales (dispositions) executed in the market. Sales by officers can be routine (for diversification, tax, or liquidity needs) and do not by themselves indicate company performance or insider sentiment. For a fuller picture, check Moore’s remaining holdings on the complete Form 4 and recent insider activity or corporate disclosures.